Stempoint Capital reported a 7.2% stake in Xilio Therapeutics XLO · 4,000,000 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 7.2%
Last report: First report
Shares held: 4,000,000 sh
Class: Common Stock, par value $0.0001 per share
Stock: Xilio Therapeutics XLO
Holder: Stempoint Capital
Event date: 25/09/30
Filed: 25/11/14

First 5%+ report · 7.2% stake

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Stempoint Capital's other 5% stake reports

Stempoint Capital
5% stakeXilio Therapeutics
5% stake
Xilio Therapeutics
XLO
9.5% stake
628,866 sh
9.5% stake
Filed 08/14
Stempoint Capital
5% stakeSurrozen
5% stake
Surrozen
SRZN
5% stake
602,798 sh
5% stake
Filed 08/14
Stempoint Capital
5% stakeFaeth Therapeutics
5% stake
Faeth Therapeutics
FTH
0% stake
0 sh
0% stake
Filed 08/14
Stempoint Capital
5% stakeCellectar Biosciences
5% stake
Cellectar Biosciences
CLRB
9.9% stake
845,740 sh
9.9% stake
Filed 08/14
Stempoint Capital
5% stakeSurrozen
5% stake
Surrozen
SRZN
4.5% stake
525,639 sh
4.5% stake
Filed 05/15